Terms: = Uterine cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Diagnosis
2 results:
1. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract] [Full Text] [Related]
2. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer.
Schwartzbaum JA; Hulka BS; Fowler WC; Kaufman DG; Hoberman D
Am J Epidemiol; 1987 Nov; 126(5):851-60. PubMed ID: 3661533
[TBL] [Abstract] [Full Text] [Related]
